Transient Receptor Potential Ion Channel-Dependent Toxicity Of Silica Nanoparticles And Poly(amido Amine) Dendrimers
Abstract
Fundamental to the design and development of nanoparticles for applications in nanomedicine is a detailed understanding of their biologic fate and potential toxic effects. Transient receptor potential (TRP) ion channels are a large superfamily of cation channels with varied physiologic functions. This superfamily is classified into six related subfamilies: TRP canonical, TRP vanilloid (TRPV), TRP melastatin (TRPM), TRP ankyrin (TRPA), TRP polycystin, and TRP mucolipin. TRPA1, TRPM2, and TRPM8 are nonselective Ca21-permeable cation channels which regulate calcium pathways under oxidative stress, whereas TRPV4 can be activated by oxidative, osmotic, and thermal stress as well as different fatty acid metabolites. Using a series of well characterized silica nanoparticles with variations in size (approximately 50-350 nm in diameter) and porosity, as well as cationic and anionic poly(amido amine) (PAMAM) dendrimers of similar size, we examined the toxicity of these nanoparticles to human embryonic kidney-293 cells overexpressing different TRP channels. The data show that the toxicity of mesoporous silica nanoparticles was influenced by expression of the TRPA1 and TRPM2 channels, whereas the toxicity of smaller nonporous silica nanoparticles was only affected by TRPM8. Additionally, TRPA1 and TRPM2 played a role in the cytotoxicity of cationic dendrimers, but not anionic dendrimers. TRPV4 did not seem to play a significant role in silica nanoparticle or PAMAM toxicity.
Recommended Citation
R. Mohammadpour et al., "Transient Receptor Potential Ion Channel-Dependent Toxicity Of Silica Nanoparticles And Poly(amido Amine) Dendrimers," Journal of Pharmacology and Experimental Therapeutics, vol. 370, no. 3, pp. 751 - 760, American Society for Pharmacology and Experimental Therapeutics (ASPET), Jan 2019.
The definitive version is available at https://doi.org/10.1124/jpet.118.253682
Department(s)
Chemical and Biochemical Engineering
International Standard Serial Number (ISSN)
1521-0103; 0022-3565
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2025 American Society for Pharmacology and Experimental Therapeutics (ASPET), All rights reserved.
Publication Date
01 Jan 2019
PubMed ID
30442652

Comments
National Science Foundation, Grant R01ES017431